ArticleCell reports2017

Targeting DNA Damage Response in Prostate Cancer by Inhibiting Androgen Receptor-CDC6-ATR-Chk1 Signaling.

Styliani Karanika et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.